Study of an Extended Release (ER) Tablet, Single and Repeated Dosing

NCT00689039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD1305
DRUG: Placebo

Sponsor

AstraZeneca